← Back to Search

Other

C-KAD Ophthalmic Solution for Asteroid Hyalosis

Phase 2
Waitlist Available
Research Sponsored by Chakshu Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Presence of asteroid hyalosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: C-KAD Ophthalmic SolutionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
C-KAD Ophthalmic Solution
2007
N/A
~20

Find a Location

Who is running the clinical trial?

Chakshu Research, Inc.Lead Sponsor
3 Previous Clinical Trials
173 Total Patients Enrolled
Ira Wong, MDStudy DirectorChakshu Research, Inc.
2 Previous Clinical Trials
92 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top